{"id":"https://openalex.org/W2020201638","doi":"https://doi.org/10.1038/sj.bjp.0701426","title":"Neuroprotective efficacy of ebselen, an anti\u2010oxidant with anti\u2010inflammatory actions, in a rodent model of permanent middle cerebral artery occlusion","display_name":"Neuroprotective efficacy of ebselen, an anti\u2010oxidant with anti\u2010inflammatory actions, in a rodent model of permanent middle cerebral artery occlusion","publication_year":1997,"publication_date":"1997-11-01","ids":{"openalex":"https://openalex.org/W2020201638","doi":"https://doi.org/10.1038/sj.bjp.0701426","mag":"2020201638","pmid":"https://pubmed.ncbi.nlm.nih.gov/9401794","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1565026"},"language":"en","primary_location":{"id":"doi:10.1038/sj.bjp.0701426","doi":"https://doi.org/10.1038/sj.bjp.0701426","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjp.0701426","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0701426","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0701426","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110174446","display_name":"Teiichi Takasago","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I173915773","display_name":"Yamaguchi University","ror":"https://ror.org/03cxys317","country_code":"JP","type":"education","lineage":["https://openalex.org/I173915773"]},{"id":"https://openalex.org/I7882870","display_name":"University of Glasgow","ror":"https://ror.org/00vtgdb53","country_code":"GB","type":"education","lineage":["https://openalex.org/I7882870"]}],"countries":["GB","JP"],"is_corresponding":false,"raw_author_name":"T. Takasago","raw_affiliation_strings":["Wellcome Surgical Institute & Hugh Fraser Neuroscience Labs., University of Glasgow","Department of Neurosurgery, Yamaguchi University School of Medicine, 1144 Kogushi, Ube, Yamaguchi 755, Japan","Wellcome Surgical Institute & Hugh Fraser Neuroscience Labs., University of Glasgow, Garscube Estate, Glasgow G61 1QH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wellcome Surgical Institute & Hugh Fraser Neuroscience Labs., University of Glasgow","institution_ids":["https://openalex.org/I7882870"]},{"raw_affiliation_string":"Department of Neurosurgery, Yamaguchi University School of Medicine, 1144 Kogushi, Ube, Yamaguchi 755, Japan","institution_ids":["https://openalex.org/I173915773"]},{"raw_affiliation_string":"Wellcome Surgical Institute & Hugh Fraser Neuroscience Labs., University of Glasgow, Garscube Estate, Glasgow G61 1QH","institution_ids":["https://openalex.org/I7882870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015733714","display_name":"E. E. Peters","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I7882870","display_name":"University of Glasgow","ror":"https://ror.org/00vtgdb53","country_code":"GB","type":"education","lineage":["https://openalex.org/I7882870"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"E. E. Peters","raw_affiliation_strings":["Wellcome Surgical Institute & Hugh Fraser Neuroscience Labs., University of Glasgow, Garscube Estate, Glasgow G61 1QH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wellcome Surgical Institute & Hugh Fraser Neuroscience Labs., University of Glasgow, Garscube Estate, Glasgow G61 1QH","institution_ids":["https://openalex.org/I7882870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072425669","display_name":"David Ian Graham","orcid":"https://orcid.org/0000-0002-6084-5676","observed_orcids":["https://orcid.org/0000-0002-6084-5676"]},"institutions":[{"id":"https://openalex.org/I2802050120","display_name":"Southern General Hospital","ror":"https://ror.org/04wvkky61","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800201399","https://openalex.org/I2802050120","https://openalex.org/I4210158502"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"D. I. Graham","raw_affiliation_strings":["University Department of Neuropathology, Institute of Neurological Sciences, Southern General Hospital, Glasgow G51 4TF"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Department of Neuropathology, Institute of Neurological Sciences, Southern General Hospital, Glasgow G51 4TF","institution_ids":["https://openalex.org/I2802050120"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024547996","display_name":"Hiroyuki Masayasu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H. Masayasu","raw_affiliation_strings":["Daiichi Pharmaceutical Co. Ltd., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Daiichi Pharmaceutical Co. Ltd., Tokyo, Japan","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033743694","display_name":"I. Mhairi Macrae","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I7882870","display_name":"University of Glasgow","ror":"https://ror.org/00vtgdb53","country_code":"GB","type":"education","lineage":["https://openalex.org/I7882870"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"I. M. Macrae","raw_affiliation_strings":["Wellcome Surgical Institute & Hugh Fraser Neuroscience Labs., University of Glasgow, Garscube Estate, Glasgow G61 1QH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wellcome Surgical Institute & Hugh Fraser Neuroscience Labs., University of Glasgow, Garscube Estate, Glasgow G61 1QH","institution_ids":["https://openalex.org/I7882870"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5033743694"],"corresponding_institution_ids":["https://openalex.org/I7882870"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":4.5292,"has_fulltext":true,"cited_by_count":162,"citation_normalized_percentile":{"value":0.94600861,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"122","issue":"6","first_page":"1251","last_page":"1256"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.7759000062942505,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.7759000062942505,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","score":0.16220000386238098,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11931","display_name":"Organoselenium and organotellurium chemistry","score":0.04170000180602074,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ebselen","display_name":"ebselen","score":1.0},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.9919999837875366},{"id":"https://openalex.org/keywords/cerebral-ischemia","display_name":"cerebral ischemia","score":0.843999981880188},{"id":"https://openalex.org/keywords/middle-cerebral-artery-occlusion","display_name":"middle cerebral artery occlusion","score":0.9610000252723694},{"id":"https://openalex.org/keywords/infarct-size","display_name":"infarct size","score":0.7409999966621399},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.6930000185966492},{"id":"https://openalex.org/keywords/oxidative-damage","display_name":"oxidative damage","score":0.7360000014305115},{"id":"https://openalex.org/keywords/antioxidant-therapy","display_name":"antioxidant therapy","score":0.671999990940094},{"id":"https://openalex.org/keywords/anti-inflammatory-agents","display_name":"anti-inflammatory agents","score":0.7710000276565552},{"id":"https://openalex.org/keywords/treatment-delay","display_name":"treatment delay","score":0.6759999990463257},{"id":"https://openalex.org/keywords/plasma-selenium","display_name":"plasma selenium","score":0.5},{"id":"https://openalex.org/keywords/caudate-nucleus","display_name":"caudate nucleus","score":0.7200000286102295},{"id":"https://openalex.org/keywords/cerebral-cortex","display_name":"cerebral cortex","score":0.6449999809265137}],"concepts":[{"id":"https://openalex.org/C2779138974","wikidata":"https://www.wikidata.org/wiki/Q5332073","display_name":"Ebselen","level":5,"score":0.9731082916259766},{"id":"https://openalex.org/C2775841333","wikidata":"https://www.wikidata.org/wiki/Q498179","display_name":"Middle cerebral artery","level":3,"score":0.7183140516281128},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.638976514339447},{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.6009554266929626},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.530888020992279},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4831759035587311},{"id":"https://openalex.org/C2779450755","wikidata":"https://www.wikidata.org/wiki/Q1209150","display_name":"Cerebral infarction","level":3,"score":0.4539314806461334},{"id":"https://openalex.org/C541997718","wikidata":"https://www.wikidata.org/wiki/Q188151","display_name":"Ischemia","level":2,"score":0.4518463611602783},{"id":"https://openalex.org/C2781041448","wikidata":"https://www.wikidata.org/wiki/Q75839","display_name":"Cerebral cortex","level":2,"score":0.43893784284591675},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2752598524093628},{"id":"https://openalex.org/C2776151105","wikidata":"https://www.wikidata.org/wiki/Q898814","display_name":"Oxidative stress","level":2,"score":0.15670549869537354},{"id":"https://openalex.org/C2775838275","wikidata":"https://www.wikidata.org/wiki/Q410776","display_name":"Superoxide dismutase","level":3,"score":0.1410064995288849},{"id":"https://openalex.org/C2778760513","wikidata":"https://www.wikidata.org/wiki/Q24773045","display_name":"Glutathione peroxidase","level":4,"score":0.1098463237285614}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000975","descriptor_name":"Antioxidants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001393","descriptor_name":"Azoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002545","descriptor_name":"Brain Ischemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011916","descriptor_name":"Rats, Inbred F344","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016566","descriptor_name":"Organoselenium Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054833","descriptor_name":"Isoindoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1038/sj.bjp.0701426","doi":"https://doi.org/10.1038/sj.bjp.0701426","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjp.0701426","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0701426","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3469886","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1565026","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:9401794","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9401794","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1565026","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1565026/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Pharmacol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1038/sj.bjp.0701426","doi":"https://doi.org/10.1038/sj.bjp.0701426","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjp.0701426","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0701426","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320311904","display_name":"Wellcome Trust","ror":"https://ror.org/029chgv08"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2020201638.pdf","grobid_xml":"https://content.openalex.org/works/W2020201638.grobid-xml"},"referenced_works_count":37,"referenced_works":["https://openalex.org/W293735132","https://openalex.org/W388660883","https://openalex.org/W1498891976","https://openalex.org/W1964998061","https://openalex.org/W1976874392","https://openalex.org/W1981705051","https://openalex.org/W1986669241","https://openalex.org/W1987402552","https://openalex.org/W1989822988","https://openalex.org/W1990484506","https://openalex.org/W1990772447","https://openalex.org/W2018363085","https://openalex.org/W2022788768","https://openalex.org/W2029411593","https://openalex.org/W2031702150","https://openalex.org/W2033573399","https://openalex.org/W2038593561","https://openalex.org/W2043423869","https://openalex.org/W2045835005","https://openalex.org/W2047814598","https://openalex.org/W2049189117","https://openalex.org/W2056593258","https://openalex.org/W2066947595","https://openalex.org/W2069250827","https://openalex.org/W2074269473","https://openalex.org/W2074524536","https://openalex.org/W2077393263","https://openalex.org/W2078018243","https://openalex.org/W2087306739","https://openalex.org/W2087651368","https://openalex.org/W2094038479","https://openalex.org/W2116495194","https://openalex.org/W2116605894","https://openalex.org/W2128417537","https://openalex.org/W2132009999","https://openalex.org/W2137232579","https://openalex.org/W2166487601"],"related_works":["https://openalex.org/W2066947595","https://openalex.org/W1989439959","https://openalex.org/W2142088831","https://openalex.org/W1988503833","https://openalex.org/W2097285853","https://openalex.org/W2054877890","https://openalex.org/W2055609777","https://openalex.org/W1967670242","https://openalex.org/W1771209779","https://openalex.org/W2122765865"],"abstract_inverted_index":{"1.":[0],"The":[1,180,203,264],"aim":[2],"of":[3,22,28,54,60,78,115,136,148,160,183,195,205,230,261,281],"this":[4,250,292],"study":[5],"was":[6,42,94,191,212,246],"to":[7,133,276],"investigate":[8],"whether":[9],"delayed":[10],"treatment":[11],"with":[12,144,175,259],"the":[13,20,52,61,76,82,106,145,158,163,176,184,196,209,241],"anti-oxidant":[14],"and":[15,48,75,84,101,119,127,166,171,219,285],"anti-inflammatory":[16],"agent":[17],"ebselen":[18,83,149,187,199,231,287],"reduces":[19],"volume":[21,159,204],"infarction":[23,161],"in":[24,81,105,162,208,249,279,290],"a":[25,273],"rodent":[26],"model":[27],"permanent":[29,58],"focal":[30],"cerebral":[31,55,64,164,167,210,220],"ischaemia.":[32],"2.":[33],"Ebselen":[34,93],"(10":[35,150,200],"or":[36,40],"30":[37,46,128,233],"mg":[38,129,151,189,201,234],"kg-1)":[39,152,190,235],"vehicle":[41],"administered":[43],"by":[44,57,89,108,214,222],"gavage":[45],"min":[47],"12":[49],"h":[50,71,110],"after":[51],"induction":[53],"ischaemia":[56,245,284],"occlusion":[59],"left":[62],"middle":[63],"artery":[65],"(MCA).":[66],"Animals":[67],"were":[68,87],"killed":[69],"24":[70],"following":[72,97],"MCA":[73],"occlusion,":[74],"volumes":[77],"ischaemic":[79,206,262],"damage":[80,207,278],"control":[85,134],"groups":[86],"evaluated":[88],"quantitative":[90],"histopathology.":[91],"3.":[92],"quickly":[95],"absorbed":[96],"oral":[98],"(gavage)":[99],"administration":[100],"reached":[102],"peak":[103],"levels":[104],"plasma":[107],"1":[109],"post-administration":[111],"(plasma":[112],"selenium":[113],"level":[114,135],"0.68":[116],"+/-":[117,121,138],"0.04":[118],"0.84":[120],"0.1":[122],"microgram":[123,140],"ml-1":[124],"for":[125],"10":[126],"kg-1,":[130],"respectively,":[131],"compared":[132,174],"0.51":[137],"0.02":[139],"kg-1).":[141,202],"4.":[142],"Treatment":[143],"lower":[146,197],"dose":[147,186,198],"significantly":[153],"(P":[154,216,224],"<":[155,217,225],"0.01)":[156],"reduced":[157,213],"hemisphere":[165,211],"cortex":[168,221],"(by":[169],"31.8%":[170],"36.7%,":[172],"respectively":[173],"placebo":[177],"group).":[178],"5.":[179],"neuroprotective":[181],"efficacy":[182,239],"higher":[185],"(30":[188],"less":[192],"than":[193],"that":[194,268,286],"23.7%":[215],"0.02),":[218],"27.5%":[223],"0.01).":[226],"6.":[227],"Both":[228],"doses":[229],"(10,":[232],"had":[236],"no":[237],"therapeutic":[238],"on":[240],"caudate":[242],"nucleus,":[243],"where":[244],"most":[247],"severe,":[248],"model.":[251],"7.":[252],"Free":[253],"radical-mediated":[254],"injury":[255,270],"is":[256,271,288],"normally":[257],"associated":[258],"reperfusion":[260],"tissue.":[263],"present":[265],"results":[266],"suggest":[267],"oxidative":[269],"also":[272],"significant":[274],"contributor":[275],"brain":[277],"models":[280],"maintained":[282],"(permanent)":[283],"effective":[289],"attenuating":[291],"free":[293],"radical-induced":[294],"damage.":[295]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":4},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}